Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) - Total Liabilities
Based on the latest financial reports, Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) has total liabilities worth Rs340.59 Million INR (≈ $3.68 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Biofil Chemicals & Pharmaceuticals Limited - Total Liabilities Trend (2008–2025)
This chart illustrates how Biofil Chemicals & Pharmaceuticals Limited's total liabilities have evolved over time, based on quarterly financial data. See BIOFILCHEM current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Biofil Chemicals & Pharmaceuticals Limited Competitors by Total Liabilities
The table below lists competitors of Biofil Chemicals & Pharmaceuticals Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Can Fite Biopharma Ltd ADR
NYSE MKT:CANF
|
USA | $3.92 Million |
|
Tambourah Metals Ltd
AU:TMB
|
Australia | AU$359.91K |
|
Amaze Holdings Inc
NYSE MKT:AMZE
|
USA | $24.44 Million |
|
Aruma Resources Ltd
AU:AAJ
|
Australia | AU$321.75K |
|
Avant Brands Inc
TO:AVNT
|
Canada | CA$24.88 Million |
|
Dreamland Limited Class A Ordinary Shares
NASDAQ:TDIC
|
USA | $49.81 Million |
|
Aquila SA
PA:ALAQU
|
France | €5.99 Million |
|
Trellidor Holdings Ltd
JSE:TRL
|
South Africa | ZAC104.77 Million |
Liability Composition Analysis (2008–2025)
This chart breaks down Biofil Chemicals & Pharmaceuticals Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BIOFILCHEM market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.44 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.01 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.60 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.62 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Biofil Chemicals & Pharmaceuticals Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Biofil Chemicals & Pharmaceuticals Limited (2008–2025)
The table below shows the annual total liabilities of Biofil Chemicals & Pharmaceuticals Limited from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs321.79 Million ≈ $3.48 Million |
+11.42% |
| 2024-03-31 | Rs288.80 Million ≈ $3.12 Million |
+104.76% |
| 2023-03-31 | Rs141.04 Million ≈ $1.53 Million |
+644.44% |
| 2022-03-31 | Rs18.95 Million ≈ $204.89K |
-88.93% |
| 2021-03-31 | Rs171.09 Million ≈ $1.85 Million |
-37.74% |
| 2020-03-31 | Rs274.82 Million ≈ $2.97 Million |
+160.16% |
| 2019-03-31 | Rs105.63 Million ≈ $1.14 Million |
-3.86% |
| 2018-03-31 | Rs109.87 Million ≈ $1.19 Million |
+20.16% |
| 2017-03-31 | Rs91.44 Million ≈ $988.88K |
-30.86% |
| 2016-03-31 | Rs132.25 Million ≈ $1.43 Million |
+147.59% |
| 2015-03-31 | Rs53.42 Million ≈ $577.66K |
-20.70% |
| 2014-03-31 | Rs67.36 Million ≈ $728.45K |
+9.87% |
| 2013-03-31 | Rs61.31 Million ≈ $663.03K |
-15.70% |
| 2012-03-31 | Rs72.73 Million ≈ $786.51K |
+97.67% |
| 2011-03-31 | Rs36.79 Million ≈ $397.89K |
-56.84% |
| 2010-03-31 | Rs85.25 Million ≈ $921.94K |
+18.42% |
| 2009-03-31 | Rs71.99 Million ≈ $778.51K |
-8.89% |
| 2008-03-31 | Rs79.01 Million ≈ $854.46K |
-- |
About Biofil Chemicals & Pharmaceuticals Limited
Biofil Chemicals and Pharmaceuticals Limited engages in manufacturing and trading of pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and … Read more